A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes.

about

A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes.

Item

http://www.wikidata.org/entity/Q47150459

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A Novel Therapeutic Strategy f ...... ne-Bearing Cationic Liposomes.

@en

A Novel Therapeutic Strategy f ...... ne-Bearing Cationic Liposomes.

@nl

type

Item

label

A Novel Therapeutic Strategy f ...... ne-Bearing Cationic Liposomes.

@en

A Novel Therapeutic Strategy f ...... ne-Bearing Cationic Liposomes.

@nl

prefLabel

A Novel Therapeutic Strategy f ...... ne-Bearing Cationic Liposomes.

@en

A Novel Therapeutic Strategy f ...... ne-Bearing Cationic Liposomes.

@nl

P1476

A Novel Therapeutic Strategy f ...... ne-Bearing Cationic Liposomes.

@en

P2093

Manjarika De

http://www.w3.org/2001/XMLSchema#string

Md Shadab

http://www.w3.org/2001/XMLSchema#string

Nahid Ali

http://www.w3.org/2001/XMLSchema#string

Santanu Basu

http://www.w3.org/2001/XMLSchema#string

Sneha Ghosh

http://www.w3.org/2001/XMLSchema#string

Triparna Sen

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.

A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells.

Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity.

Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model.

Increased exposure of anionic phospholipids on the surface of tumor blood vessels.

Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors.

Phosphatidylserine, a death knell.

Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro.

Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.

Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo.

P304

9-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTN.2017.10.019

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Indranil Banerjee

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29499959

http://www.w3.org/2001/XMLSchema#string

P932

5723379

http://www.w3.org/2001/XMLSchema#string